Cas Medical Systems Inc (NASDAQ:CASM) Stock Price While Sentiment Worsens

January 9, 2018 - By Clifton Ray

 Cas Medical Systems Inc (NASDAQ:CASM) Stock Price  While Sentiment  Worsens

Sentiment for Cas Medical Systems Inc (NASDAQ:CASM)

Cas Medical Systems Inc (NASDAQ:CASM) institutional sentiment decreased to 0.83 in Q3 2017. Its down -0.37, from 1.2 in 2017Q2. The ratio fall, as 5 investment managers increased and opened new positions, while 6 trimmed and sold stock positions in Cas Medical Systems Inc. The investment managers in our partner’s database now have: 6.37 million shares, up from 6.06 million shares in 2017Q2. Also, the number of investment managers holding Cas Medical Systems Inc in their top 10 positions was flat from 0 to 0 for the same number . Sold All: 2 Reduced: 4 Increased: 3 New Position: 2.

CAS Medical Systems, Inc., a non-invasive cerebral oximetry technology company, develops, makes, and markets non-invasive patient monitoring products worldwide. The company has market cap of $27.88 million. The Company's FORE-SIGHT® Absolute Cerebral Oximeter provides non-invasive and continuous measurement of absolute cerebral tissue oxygenation in the brain for patients during critical care. It currently has negative earnings. The firm provides FORE-SIGHT tissue oximeter monitors, sensors, and accessories.

The stock decreased 3.77% or $0.04 during the last trading session, reaching $1.02. About 94,888 shares traded. CAS Medical Systems, Inc. (NASDAQ:CASM) has declined 47.56% since January 9, 2017 and is downtrending. It has underperformed by 64.26% the S&P500.

Analysts await CAS Medical Systems, Inc. (NASDAQ:CASM) to report earnings on March, 8. They expect $-0.08 earnings per share, down 14.29 % or $0.01 from last year’s $-0.07 per share. After $-0.01 actual earnings per share reported by CAS Medical Systems, Inc. for the previous quarter, Wall Street now forecasts 700.00 % negative EPS growth.

Acuta Capital Partners Llc holds 0.84% of its portfolio in CAS Medical Systems, Inc. for 5.09 million shares. 1492 Capital Management Llc owns 42,346 shares or 0.03% of their US portfolio. Moreover, Manatuck Hill Partners Llc has 0.02% invested in the company for 50,000 shares. The Tennessee-based Td Capital Management Llc has invested 0.01% in the stock. Blackrock Inc., a New York-based fund reported 11,354 shares.#img1#

More notable recent CAS Medical Systems, Inc. (NASDAQ:CASM) news were published by: Seekingalpha.com which released: “CAS Medical Systems’ (CASM) CEO Tom Patton on Q1 2017 Results – Earnings Call …” on May 03, 2017, also Seekingalpha.com with their article: “CASMED reports preliminary Q4 revenue; shares +14%” published on January 04, 2018, Globenewswire.com published: “CASMED Sells Non-invasive Blood Pressure Monitoring Product Line to SunTech …” on July 26, 2017. More interesting news about CAS Medical Systems, Inc. (NASDAQ:CASM) were released by: Seekingalpha.com and their article: “CAS Medical Systems’ (CASM) CEO Tom Patton on Q3 2017 Results – Earnings Call …” published on November 12, 2017 as well as Globenewswire.com‘s news article titled: “CASMED Names Kimberly Strusky Executive Vice President of US Sales” with publication date: October 05, 2015.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: